Ning-Ai Liu MD
Diabetes, Lipid Metabolism
Assistant Professor, Medicine, UCLA School of Medicine
Join to View Full Profile
127 S San Vicente BlvdPavilion, Suite A6600Los Angeles, CA 90048
Phone+1 310-423-2830
Fax+1 310-423-2819
Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ning-Ai Liu, MD, is an endocrinologist based in Los Angeles, CA with specific expertise in pituitary disease, parathyroid and bone disease. Her medical education began at Shanghai Medical College, Fudan University (formerly Shanghai Medical University), followed by residency in Internal Medicine at Medical College of Georgia and an endocrinology fellowship at Cedars-Sinai Medical Center. She has significant experience in treating pituitary-related disorders, osteoporosis, and parathyroid disease. Dr. Liu has also contributed to a range of clinical trials and authored multiple publications, including in highly regarded journals like The Journal of Clinical Endocrinology and Metabolism. In 2013, she received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation.
Education & Training
Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
Medical College of GeorgiaResidency, Internal Medicine, 1996 - 1999
Shanghai Medical College of Fudan UniversityClass of 1985
Certifications & Licensure
CA State Medical License 2001 - 2025
GA State Medical License 1998 - 2001
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Treatment of Cushing's Disease With R-roscovitine Start of enrollment: 2014 May 01
- SOM230 Ectopic ACTH-producing Tumors Start of enrollment: 2015 Dec 01
- Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease Start of enrollment: 2018 Nov 02
Publications & Presentations
PubMed
- 1 citationsFluid Restriction Reduces Delayed Hyponatremia and Hospital Readmissions After Transsphenoidal Surgery.Odelia Cooper, Rita Lis, Vivien Bonert, Artak Labadzhyan, Ning-Ai Liu
The Journal of Clinical Endocrinology and Metabolism. 2023-07-14 - 14 citationsTreatment of Cushing Disease With Pituitary-Targeting Seliciclib.Ning-Ai Liu, Anat Ben-Shlomo, John D Carmichael, Christina Wang, Ronald S Swerdloff
The Journal of Clinical Endocrinology and Metabolism. 2023-02-15 - 5 citationsA Rare Case: Adrenal Corticomedullary Mixed Tumor With Elements of Pheochromocytoma, Cortical Adenoma, and Ganglioneuroma Cells.Erica Patel, Yufei Chen, Xuemo Fan, Ning-Ai Liu, Anne Marie Westreich
AACE Clinical Case Reports. 2022-12-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
